Agno Pharma Acquires Actylis Eugene (Legacy Cascade Chemistry) in Eugene, Oregon

January 15, 2026

Agno Pharma has acquired Actylis Eugene, the legacy Cascade Chemistry manufacturing asset in Eugene, Oregon, expanding Agno's U.S. cGMP API development and manufacturing footprint. The site includes a 16,000 sq. ft. R&D lab and a newly constructed 30,000 sq. ft. GMP manufacturing facility, enhancing Agno's capabilities to support biotech and pharmaceutical clients from early-phase through commercial API production.

Buyers
Agno Pharma
Targets
Actylis Eugene (legacy Cascade Chemistry business)
Sellers
Actylis
Industry
Pharmaceuticals
Location
Oregon, United States
Transaction Type
Buyout

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →